Viking Therapeutics (VKTX) Q4 2020 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2020.
Viking Therapeutics(VKTX)
Nasdaq Capital Market (Nasdaq)
VKTX
$5.90
$0.04
0.8%
Price as of April 13, 2021, 8:00 p.m. EDT
View Interactive VKTX Charts
Viking Therapeutics, Inc.
Interactive Chart
News & Analysis: Viking Therapeutics
The Fool has written over 100 articles on Viking Therapeutics.
Viking Therapeutics (VKTX) Q3 2020 Earnings Call Transcript
VKTX earnings call for the period ending September 30, 2020.
2 Great Stocks Under $10
Bargain stocks don't come much cheaper than this.
Viking Therapeutics (VKTX) Q2 2020 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2020.
Viking Therapeutics Inc (VKTX) Q1 2020 Earnings Call Transcript
VKTX earnings call for the period ending March 31, 2020.
Here's Why Viking Therapeutics Tumbled 20.9% in March
The small-cap pharma stock didn't stand a chance in the broader market volatility.
Top Drug Stocks Under $5
Healthcare bargain hunters can find good values in quality low-priced stocks.
Top Pharma Stocks Under $5
These clinical-stage drugmakers could be a steal at current levels.
Viking Therapeutics Inc (VKTX) Q4 2019 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2019.
Is Viking Therapeutics' Stock a Buy?
Targeting a large and growing disease state, this drug developer's stock requires patience to reap future rewards.
